GE HealthCare Technologies Inc. (GEHC) Guidance & Earnings Results

On 2026-07-29 GE HealthCare Technologies Inc. reaffirmed guidance: "FY26 organic revenue growth 3.0%-4.0%; adjusted EBIT margin 15.4%-15.7% (+10-40bps YoY); adjusted EPS $4.80-$5.00 (+4.6%-9.0% YoY); free cash flow ~$1.6B; adjusted ETR…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

GEHCGE HealthCare Technologies Inc.Follow GEHC — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 32.3B
P/E TTM: 16.4
Dividend yield: 0.2%
52-week: —
Next earnings: 28 Oct, in 4 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
29 Jul 26	Reaffirmed	FY26 organic revenue growth 3.0%-4.0%; adjusted EBIT margin 15.4%-15.7% (+10-40bps YoY); adjusted EPS $4.80-$5.00 (+4.6%-9.0% YoY); free cash flow ~$1.6B; adjusted ETR 20.0%-21.0% · full year
23 Jul 26	Reaffirmed	Full-year 2026 guidance reaffirmed · full year
29 Apr 26	Lowered	Reducing profit and free cash flow outlook; expect mid- to high-single digit Adjusted EPS growth · full year
4 Feb 26	Raised	FY2026 revenue growth 4%-6% · full year
29 Oct 25	Raised	Adjusted EPS guidance raised to $4.51-$4.63 from $4.43-$4.63 · full year
30 Jul 25	Raised	FY25 organic revenue growth ~3% (prev 2-3%); adj. EBIT margin 15.2-15.4% (prev 14.2-14.4%); adj. ETR 20-21% (prev 21-22%); adj. EPS $4.43-$4.63 (prev $3.90-$4.10); FCF at least $1.4B (prev at least $1.2B) · full year

GE HealthCare Technologies Inc. — questions

What guidance did GE HealthCare Technologies Inc. give?: On 2026-07-29: "FY26 organic revenue growth 3.0%-4.0%; adjusted EBIT margin 15.4%-15.7% (+10-40bps YoY); adjusted EPS $4.80-$5.00 (+4.6%-9.0% YoY); free cash flow ~$1.6B; adjusted ETR 20.0%-21.0%"
When does GE HealthCare Technologies Inc. report earnings?: GE HealthCare Technologies Inc.'s next earnings report is expected on 2026-10-28.

Every figure on this page comes from GE HealthCare Technologies Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.